 |
인쇄하기
취소
|
Daewoong to conduct phase I trial for investigational neuropathic pain product
Daewoong Pharm says it will conduct a phase I study for its investigational neuropathic pain product (DWP05195) after approval from the Korea Food and Drug Administration.
According to the company, the phase I study will be conducted in Seoul National University Hospital in order to determine that DWP05195 is safe and well tolerated in healthy subjects.
Daewoong officials said DWP05195 ma...
According to the company, the phase I study will be conducted in Seoul National University Hospital in order to determine that DWP05195 is safe and well tolerated in healthy subjects.
Daewoong officials said DWP05195 ma...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.